TNBC's compass: Navigating prognosis with a cellular map
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers discovered a stem-like tumor cell associated with poor outcomes in triple-negative breast cancer (TNBC). This finding, combined with T cell data, creates a new classification system for predicting prognosis and guiding treatment.
Area Of Science
- Oncology
- Immunology
- Biomedical Imaging
Background
- Triple-negative breast cancer (TNBC) presents significant therapeutic challenges.
- Identifying novel biomarkers for TNBC prognosis is crucial for effective treatment strategies.
Purpose Of The Study
- To identify novel tumor cell subtypes in TNBC.
- To correlate tumor cell characteristics and T cell spatial architecture with patient prognosis.
- To develop a new classification system for TNBC.
Main Methods
- Utilized imaging mass cytometry to analyze tumor tissue.
- Integrated spatial analysis of T cells within the tumor microenvironment.
- Correlated identified cell types and spatial patterns with clinical outcome data.
Main Results
- Identified a distinct stem-like basoluminal tumor cell population.
- This cell type is significantly associated with poor prognosis in TNBC patients.
- Established a five-subtype classification integrating tumor cell phenotype and T cell spatial organization.
Conclusions
- The stem-like basoluminal tumor cell is a potential prognostic biomarker for TNBC.
- The developed five-subtype classification system can predict prognosis and inform therapeutic decisions in TNBC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...